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Previously unknown or unexpected pathogens may be responsible for that proportion
of respiratory diseases in which a causative agent cannot be identiﬁed. The application
of broad-spectrum, sequence independent virus discovery techniques may be useful to
reduce this proportion and widen our knowledge about respiratory pathogens. Thanks to
the availability of high-throughput sequencing (HTS) technology, it became today possible
to detect viruses which are present at a very low load, but the clinical relevance of those
viruses must be investigated. In this study we used VIDISCA-454, a restriction enzyme
based virus discovery method that utilizes Roche 454 HTS system, on a nasal swab
collected from a subject with respiratory complaints. A γ-papillomavirus was detected
(complete genome: 7142 bp) and its role in disease was investigated. Respiratory samples
collected both during the acute phase of the illness and 2 weeks after full recovery
contained the virus. The patient presented antibodies directed against the virus but there
was no difference between IgG levels in blood samples collected during the acute phase
and 2 weeks after full recovery.We therefore concluded that the detected γ-papillomavirus
is unlikely to be the causative agent of the respiratory complaints and its presence in the
nose of the patient is not related to the disease. Although HTS based virus discovery
techniques proved their great potential as a tool to clarify the etiology of some infectious
diseases, the obtained information must be subjected to cautious interpretations. This
study underlines the crucial importance of performing careful investigations on viruses
identiﬁed when applying sensitive virus discovery techniques, since the mere identiﬁcation
of a virus and its presence in a clinical sample are not satisfactory proofs to establish a
causative link with a disease.
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INTRODUCTION
Acute respiratory tract infections (ARTIs) can be caused by a wide
variety of pathogens, among which viruses and bacteria are the
main agents involved. Still, even with the sensitive diagnostic
assays employed nowadays, a substantial amount of respiratory
diseases cannot be attributed to any of the known commonly
involvedmicroorganisms (Tsolia et al., 2004; van de Pol et al., 2006;
Regamey et al., 2008).
The existence of previously unknown or unexpected respi-
ratory pathogens can be postulated as an explanation of this
phenomenon. Furthermore, the pool of human respiratory
viruses keeps growing because of the continuous introduction
of “novel” pathogenic viruses from the animal reservoir (Neu-
mann et al., 2009; Memish et al., 2014). These viruses need to
be quickly identiﬁed and characterized, since they might rep-
resent a signiﬁcant public health concern (Peiris et al., 2004).
In both cases the application of broad-spectrum virus discov-
ery techniques can be useful to detect previously unrecognized
or emerging pathogens, and the introduction in the market
of high-throughput sequencing (HTS) methodologies consid-
erably improved the efﬁcacy of such methods (Mokili et al.,
2012).
One of these methods is VIDISCA-454, a restriction enzyme
based virus discovery technique which was developed in our labo-
ratory and utilizes Roche-454 as HTS method (deVries et al., 2011,
2012). This technique provides the broad-spectrum approach
needed to identify novel or unexpected viruses (Oude Munnink
et al., 2014). In this study, we used VIDISCA-454 to investigate
a nasal swab – that tested negative to the principal respiratory
pathogens – collected from a patient with respiratory complaints
to determine whether an unknown virus could be the cause of the
disease.
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Among the obtained sequence reads an unexpected virus was
found, a papillomavirus. Papillomaviruses carry a circular dou-
ble stranded DNA genome, are non-enveloped and are known
for their capacity to induce warts and benign lesions of mucous
membranes (condylomas; Howley and Lowy, 2007). Some human
papillomaviruses (HPVs) can cause cancers, of which cervical can-
cer is the most notorious (Bosch et al., 1995). HPVs are not known
as causative agents of respiratory infections, although some stud-
ies report the presence of different HPVs types in the respiratory
tract of infants with respiratory diseases but also in healthy adults
(Kurose et al., 2004; Martinelli et al., 2012; Forslund et al., 2013;
Mokili et al., 2013). HPVs are also involved in recurrent respi-
ratory papillomatosis (RRP), a disease characterized by growth
of tumors around the vocal cords and in the larynx (Mammas
et al., 2014). The pathogenic role of HPVs seems to be genus/type
speciﬁc: cervical cancer and RRP are induced by α-HPVs (par-
ticularly types 16, 18, in cervical cancer, type 11 and 6 in RRP),
while γ-HPVs are known to be causative agents of warts or skin
lesions. Furthermore, several HPVs, especially from the δ- and γ-
genus, can be detected on healthy normal skin (Astori et al., 1998;
Antonsson et al., 2000; Li et al., 2012).
Since the high sensitivity of HTS based virus discoverymethods
makes it possible to identify viruses which are present in a clinical
sample at a very low concentration, questions about the clinical
relevance of those microorganisms might rise. The scope of this
study was to determine whether a correlation could be demon-
strated between the γ-HPV – identiﬁed with VIDISCA-454 – and
the clinical respiratory manifestations of the patient.
MATERIALS AND METHODS
PATIENT INFORMATION
The sample was collected from a 64-year-old heavy smoking male
patient (deﬁned from now on as the index patient) during a
visit to his local general practitioner where he reported symp-
toms of a respiratory tract infection. The onset of symptoms
was 2 days before visiting his general practitioner. Symptoms
included cough, phlegm production, shortness of breath, wheeze,
coryza, fever, chest pain, muscle aching, and headache. Dur-
ing this ﬁrst visit respiratory specimens (nasopharyngeal ﬂocked
swabs: NPFS, Copan) from each nostril (one in universal trans-
port medium: UTM – the other in skimmed milk) and serum
were collected (Visit 1: V1). The patient was part of the GRACE
study, a randomized antibiotics placebo-controlled double-blind
trial (www.grace-lrti.org), and received antibiotics (amoxicillin).
A chest X-ray was performed and the patient kept a diary to
monitor the course of symptoms and their severity. Fourteen
days after onset of symptoms the patient fully recovered. Four
weeks after the ﬁrst visit the patient underwent a check up visit
and again specimens from each nostril and serum were col-
lected (Visit 2: V2). The NPFS of the ﬁrst and second visit
were screened for the presence of known respiratory pathogens
associated with ARTI: adenovirus, respiratory syncytial virus,
human metapneumovirus, inﬂuenza A and B, parainﬂuenza
viruses 1–4, humanbocavirus, human coronaviruses (229E,OC43,
and NL63), human rhinovirus, polyomaviruses WU and KI,
Mycoplasma pneumoniae, Chlamydophila pneumoniae, Bordetella
pertussis, Legionella pneumophila, Streptococcus pneumoniae, and
Haemophilus spp (Loens et al., 2012). All diagnostics remained
negative.
ETHICAL APPROVAL
Ethics review committee of Cardiff and Southampton (UK)
approved the study and written informed consent was provided
by the participants (Loens et al., 2012).
VIRUS DISCOVERY: VIDISCA-454
VIDISCA-454 (virus discovery cDNA-AFLP, ampliﬁed fragment-
length polymorphism combined with Roche 454 high-throughput
sequencing) was performed with 110 μl of sample resuspended in
UTMaspreviously described (deVries et al., 2011). Obtained reads
were compared to known sequences present in the non-redundant
database using the BLAST tool (Altschul et al., 1990).
FULL GENOME SEQUENCING
The γ-papillomavirus fragments identiﬁed after performing
VIDISCA-454 were used as template for primer design and PCRs
were performed using the Expand Long Template PCR system
(Roche). The complete genome was obtained by sequencing two
large ampliﬁed fragments which were overlapping on both sides
for at least 400 nucleotides. Fragments were cloned into a XL-
TOPO-kit (invitrogen), and sequenced (BigDye® Terminator v1.1
Cycle SequencingKit,AppliedBiosystems). Primer sequences used
in this study are available on request.
PROTEIN EXPRESSION
The full late gene L1 (coding for the major capsid protein) was
ampliﬁed with the Expand Long Template PCR system (Roche),
cloned into pET100D expression vector (Invitrogen), and trans-
formed into chemically competent Escherichia coli BL21-derived
strain Rosetta 2 (Novagen). Overnight cultures of the transformed
bacteria were inoculated into Luria broth medium, supplemented
with 1% glucose, carbenicillin (10 μg/ml), and chloramphenicol
(17.5 μg/ml). Cultures were grown to the exponential phase prior
to induction with 0.5 mM isopropyl-β-D-thiogalactopyranoside
(IPTG) for 5 h. Samples were collected every hour to monitor the
L1-protein production. Attempts to purify the protein via Ni-NTA
resin (Qiagen) failed, probably due to the formation of aggregates
that shield the HIS-Tags; therefore the crude harvest was used to
determine the reactivity of V1 and V2 serum on Western blot.
SDS PAGE AND WESTERN BLOT
Protein production on SDS-Page was visualized by coomassie
staining and SDS-page gels were blotted onto PVDF (Millipore)
membranes. The blots were incubated with 1:600 dilutions of
either V1 or V2 serum, and with a 1:1000 dilution of a rabbit anti
HIS-tag, followed by incubation with anti-human IRDye800CW
(1:5000, Jackson Immunoresearch) and anti-rabbit DyLight649
(1:5000). Signals were measured via the Odyssey infrared imag-
ing system (LI-COR). The intensity of the signals was normalized
with the anti-HIS signal to correct for difference in protein
concentrations.
SCREENING BY REAL TIME PCR
Real time PCRs were performed with the Platinum® qPCR-kit
(Invitrogen) on an ABI PRISM 7000 sequence detection system
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of Applied biosystems according to the manufacturer’s proto-
col, using the following primers and probe: RTForward-540–570:
5′-CATACCCTAACGAAGAGGTAGCAGAC-3′, RTReverse-675–
700: 5′-TGGCGGGCAACTGCCTTTATCTAG-3′, RTProbe-620–
650: 5′ FAM-GGGCTGTATTCCGCCAACTGGTGAATATTGGG-
ATG -TAMRA 3′.
Screeningwasperformed induplicate on54 respiratory samples
collected frompatients with respiratory complaints involved in the
GRACE study (Loens et al., 2012; 25 of which from the same city
of the index patient) and only samples having detectable virus in
both tests were considered positive.
RESULTS
A NPFS was collected from a 64 years old man with respiratory
symptoms and the diagnostics for the most common respira-
tory viruses and bacteria remained negative. After performing
virus discovery a total of 13,452 sequence reads were obtained
and compared with all known sequences in GenBank (NCBI).
Among these, 10 sequences showed signiﬁcant identity to HPVs.
By genome walking the entire sequence of the virus (named HPV
isolate A2619) was determined: the viral genome is 7142 bp in
size, circular and 99% identical to the recently describedHPV-KC5
isolate (GenBank accession number: JX444073; Li et al., 2012).
CORRELATION BETWEEN HPV-A2619 AND THE RESPIRATORY DISEASE
The γ-HPVs are not known as respiratory pathogens and their
role in any disease is still uncertain. Therefore, we considered it
important to investigate the possible correlation between this virus
and the respiratory symptoms of the patient: speciﬁc diagnostic
tests were developed and applied.
Since the patient fully recovered after 14 days of illness, an
increase of the speciﬁc antibody response to the responsible
pathogen was expected, along with viral clearance. We examined
the clearance of the virus with an HPV-A2619 strain speciﬁc real
time PCR targeting the L1 gene. The virus was detected in the
NPFS of both nostrils at V1, but also in the NPFS of both nos-
trils after the patient recovered (V2). The viral load in all samples
was very low, between 2E3 and 2E4 copies/mL, and the Ct values
were similar for all samples (V1-right nostril 38.93, V1-left nostril
40.60, V2-right nostril 42.90, and V2-left nostril 37.47).
Furthermore, western blot analysis was used to detect anti-
bodies directed against the L1 capsid protein in serum samples
collected at the same time as the 2 respiratory samples. A poor
recognition of the protein was observed and no difference between
V1 or V2 serum was noticed: the two samples had similar
intensity ratios (10.78% for V1 serum; 10.76% for V2 serum;
Figure 1).
SCREENING
Respiratory samples of 54 other patients from the GRACE study
with respiratory tract infection were used for prevalence infer-
ence. Of these, 25 were from the same geographical area of the
index patient and 39 from other European cities. Two patients
(3.7%) were positive for HPV-A2619. In both patients also a low
viral copy number was detected (between 2E3 and 2E4 copies/ml).
Both patients came from the same city in the UK as the index
case.
FIGURE 1 | No increase in antibody levels directed to γ-papillomavirus
A2619. Visit 1 (V1) and Visit 2 (V2) sera were diluted 1:600 and incubated on
Western blot containing a dilution series of L1 protein.
DISCUSSION
γ-HPVs AND RESPIRATORY INFECTIONS
Not much is known about γ-papillomaviruses (γ-HPVs). Occa-
sionally γ-HPVs have been related to skinwarts or keratotic lesions
of immunosuppressed organ transplant recipients (e.g., HPV-
4; Köhler et al., 2011), but these viruses can also be detected
on healthy skin (Astori et al., 1998; Antonsson et al., 2000; Li
et al., 2012), indicating that they might not be pathogenic in
healthy individuals or only when speciﬁc conditions are ful-
ﬁlled. We identiﬁed a γ-HPV in the respiratory tract of a
patient with symptoms of a respiratory tract infection but, since
the virus was still detectable after full recovery and no rise in
antibodies was observed, we concluded that the virus was not
the causative agent of the respiratory disease of this patient.
Careful inspection of the chest X-ray also did not reveal any
cancer-related abnormalities within the lungs; furthermore also
no skin warts or abnormalities on the skin were noted. It is
therefore most likely that HPV-A2619, which we describe here,
is a harmless and ubiquitous γ-HPV which can be present in
nostrils.
HPV-A2619 resulted 99% identical to the previously reported
HPV-KC5 which was isolated from normal skin of healthy indi-
viduals in a rural area in China (Li et al., 2012), suggesting that
the virus is not geographically restricted to one location, as our
screening results might have indicated. Furthermore, it might be
argued that the virus was introduced in the respiratory tract after
contact with contaminated skin during nasal swabbing, but the
fact that the virus was persistently present in each nostril at two
time points suggests that virus is genuinely present in the nose, as
well as on normal skin.
In literature it is described that some types of HPV can cause
human papillomatosis, lesions in the respiratory tract that need
to be surgically removed, and in most cases it is a recurring prob-
lem and multiple surgical treatments are needed (Mammas et al.,
2014). The patient described here did not have a history of human
papillomatosis, and the symptoms lasted only for 14 days, thus
no indication could be found that human papillomatosis was
involved. It has also been suggested that HPV, particularly type
16, can play a role in oropharyngeal cancers (D’Souza et al., 2007);
however, the clinical data from this patient gave no evidences of
tumor.
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We therefore concluded that HPV-A2619 does not have a spe-
ciﬁc pathogenic role in a detectable disease and our results are
in agreement with other studies which reported the presence of
HPVs in the respiratory tract (Kurose et al., 2004; Martinelli et al.,
2012; Forslund et al., 2013; Mokili et al., 2013).
SENSITIVE METAGENOMIC METHODS AND PATHOGEN DISCOVERY
Thanks to the advances in molecular biology – especially the
development of next generation HTS methods – virus discov-
ery techniques became extremely sensitive and VIDISCA-454 (the
method developed in our laboratory) is not an exception (deVries
et al., 2011, 2012). The load of HPV-A2619 was determined by
real time PCR, and only 200 copies per 100 μl (input inVIDISCA)
were measured. This sensitivity is remarkable and might be related
to the nature of the virus. HPVs carry a double stranded DNA
genome and their detection by VIDISCA-454 does not depend
on reverse transcription and second strand synthesis, procedures
which decrease the detection potential of RNA viruses.
With state of the art HTS based virus discovery techniques
and the possibility to obtain such a huge number of sequences
from a clinical sample, the identiﬁcation of novel viruses became
very effective, and nowadays the detection of low load viruses
is not uncommon since minority nucleic acids can be efﬁciently
sequenced (Mokili et al., 2012; Cotten et al., 2014). These methods
are exclusively based on random sequencing of nucleic acids and
they do not provide further information beyond the recognition of
viral genetic material in a clinical sample, which does not necessar-
ily correlate with the presence of a pathogen in the sample. In fact,
some of these sequences might be derived from contaminating
viruses introduced during the sampling or the sample process-
ing procedures (Naccache et al., 2013). It is therefore important
to conﬁrm the presence of the recognized viruses in the original
sample and to investigate the clinical relevance of every discovery
to avoid drawing false conclusions.
With the development of HTS techniques the experimental
time needed to discover novel viruses has dramatically reduced.
However, targeted experiments and careful evaluation of all avail-
able data are essential to assess the relevance of every ﬁnding
and to determine the role of every identiﬁed virus, since – as
we show here – the mere identiﬁcation of a virus is not suf-
ﬁcient to prove its involvement in a disease. This is especially
true when dealing with body parts which are contiguous with the
external environment – like the respiratory tract – and therefore
more subjected to the presence of bystander or non-host-speciﬁc
microorganisms.
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